249 related articles for article (PubMed ID: 18606868)
1. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.
Flores M; Saavedra R; Bautista R; Viedma R; Tenorio EP; Leng L; Sánchez Y; Juárez I; Satoskar AA; Shenoy AS; Terrazas LI; Bucala R; Barbi J; Satoskar AR; Rodriguez-Sosa M
FASEB J; 2008 Oct; 22(10):3661-71. PubMed ID: 18606868
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection.
Terrazas CA; Juarez I; Terrazas LI; Saavedra R; Calleja EA; Rodriguez-Sosa M
Exp Parasitol; 2010 Nov; 126(3):348-58. PubMed ID: 20331989
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
Kim JH; Lee J; Bae SJ; Kim Y; Park BJ; Choi JW; Kwon J; Cha GH; Yoo HJ; Jo EK; Bae YS; Lee YH; Yuk JM
Sci Rep; 2017 Jul; 7(1):6361. PubMed ID: 28743960
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Marcon CF; Ferreira PTM; Franco PS; Ribeiro M; Silva RJ; Sousa RAP; Oliveira CJF; Rodrigues Junior V; Gomes MLM; Lazo Chica JE; Mineo TWP; Mineo JR; Barbosa BF; Ferro EAV; Gomes AO
Cytokine; 2020 Dec; 136():155283. PubMed ID: 32947151
[TBL] [Abstract][Full Text] [Related]
5. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
6. MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.
Ruiz-Rosado Jde D; Olguín JE; Juárez-Avelar I; Saavedra R; Terrazas LI; Robledo-Avila FH; Vazquez-Mendoza A; Fernández J; Satoskar AR; Partida-Sánchez S; Rodriguez-Sosa M
Mediators Inflamm; 2016; 2016():9101762. PubMed ID: 27057101
[TBL] [Abstract][Full Text] [Related]
7. MIF participates in Toxoplasma gondii-induced pathology following oral infection.
Cavalcanti MG; Mesquita JS; Madi K; Feijó DF; Assunção-Miranda I; Souza HS; Bozza MT
PLoS One; 2011; 6(9):e25259. PubMed ID: 21977228
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
9. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Migration Inhibitory Factor contributes to drive phenotypic and functional macrophages activation in response to Toxoplasma gondii infection.
Ferreira PTM; Oliveira-Scussel ACM; Sousa RAP; Gomes BQ; Félix JE; Silva RJ; Millian IB; Assunção TSF; Teixeira SC; Gomes MLM; Silva MV; Barbosa BF; Rodrigues Junior V; Mineo JR; Oliveira CJF; Ferro EAV; Gomes AO
Immunobiology; 2023 May; 228(3):152357. PubMed ID: 36857907
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor regulates innate γδ T-cell responses
Kim HK; Garcia AB; Siu E; Tilstam P; Das R; Roberts S; Leng L; Bucala R
FASEB J; 2019 Jun; 33(6):6919-6932. PubMed ID: 30817226
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 and Galectin-9 May Differently Regulate the Expressions of Microglial M1/M2 Markers and T Helper 1/Th2 Cytokines in the Brains of Genetically Susceptible C57BL/6 and Resistant BALB/c Mice Following Peroral Infection With
Liu J; Huang S; Lu F
Front Immunol; 2018; 9():1648. PubMed ID: 30108583
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
[TBL] [Abstract][Full Text] [Related]
14. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.
Brown CR; Hunter CA; Estes RG; Beckmann E; Forman J; David C; Remington JS; McLeod R
Immunology; 1995 Jul; 85(3):419-28. PubMed ID: 7558130
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types.
Angeloni MB; Silva NM; Castro AS; Gomes AO; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Sep; 30(9):785-91. PubMed ID: 19643475
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production.
Barbosa BF; Paulesu L; Ietta F; Bechi N; Romagnoli R; Gomes AO; Favoreto-Junior S; Silva DA; Mineo JR; Mineo TW; Ferro EA
Placenta; 2014 Mar; 35(3):152-62. PubMed ID: 24433846
[TBL] [Abstract][Full Text] [Related]
17. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.
Wang X; Kang H; Kikuchi T; Suzuki Y
Infect Immun; 2004 Aug; 72(8):4432-8. PubMed ID: 15271900
[TBL] [Abstract][Full Text] [Related]
18. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.
Johnson LL; Sayles PC
Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181
[TBL] [Abstract][Full Text] [Related]
19. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
Stojanovic I; Mirkov I; Kataranovski M; Glamoclija J; Stosic-Grujicic S
Immunobiology; 2011 Sep; 216(9):1018-27. PubMed ID: 21489649
[TBL] [Abstract][Full Text] [Related]
20. Altered Macrophage and Dendritic Cell Response in
Sánchez-Zamora YI; Juarez-Avelar I; Vazquez-Mendoza A; Hiriart M; Rodriguez-Sosa M
J Diabetes Res; 2016; 2016():7053963. PubMed ID: 27699180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
